XGN
EXAGEN INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$8.51
+2.04%Oct 27, 2026, 13:00 UTC
EXAGEN INC. announced that it will release financial results for the quarter ended September 30, 2026, before the market opens on November 10, 2026.
Source:Oct 23, 2026, 00:00 UTC
The Planning Inspectorate approved EXAGEN INC.’s 25MW solar plant at appeal after BROADLAND DISTRICT COUNCIL had refused it.
Source:Aug 4, 2026, 12:00 UTC
Exagen Inc. reported its financial results for the quarter ended June 30, 2026, achieving record total revenue, test volume, and trailing twelve-month ASP, reducing net loss by nearly 30%, and narrowing adjusted EBITDA loss to $0.1 million.